Jennifer Viera | IR |
Jay Luly | President and CEO |
Paul Mellett | CFO |
Nathalie Adda | Chief Medical Officer |
Brian Abrahams | RBC Capital Markets |
Yasmeen Rahimi | Piper Sandler |
Roy Buchanan | JMP Securities |
Zegbeh Jallah | ROTH Capital |
Jay Olson | Oppenheimer |
Brian Skorney | Baird |
Roanna Ruiz | SVB Leerink |
Liisa Bayko | Evercore ISI |
Good afternoon and welcome to the Enanta Pharmaceuticals Fiscal First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Investor Relations.